Abbott India net profit rises 70.78 percent at Rs 82.40 crores
Mumbai: Pharma Major, Abbott India Ltd has posted a rise of 70.78 percent in its net profit at Rs 82.40 crores for the quarter ended June 30, 2018, as against Rs 48.25 crores for the quarter ended June 30, 2017.
Total Income for the quarter ended June 2018 rose by 18.62 percent to Rs 866.68 crores as compared to Rs 730.64 crores during the 3 months period ended June 30, 2017, company said in a filing with BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd